Diametric Capital, LP Adicet Bio, Inc. Transaction History
Diametric Capital, LP
- $118 Million
- Q4 2024
A detailed history of Diametric Capital, LP transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Diametric Capital, LP holds 85,517 shares of ACET stock, worth $73,544. This represents 0.07% of its overall portfolio holdings.
Number of Shares
85,517
Previous 109,783
22.1%
Holding current value
$73,544
Previous $158,000
48.1%
% of portfolio
0.07%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59MCall Options Held
7.3KPut Options Held
39.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$9.84 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$7.01 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$6.49 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.76 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $34.4M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...